Atlas Trials

Melphalan on Disease Burden Measured by Next Generation Sequencing Before AHCT (Autologous Hematopoietic Cell Transplant) for Multiple Myeloma

Clinical trial NCT05013437 · WITHDRAWN

Trial details

NCT number
NCT05013437
Sponsor
Koen van Besien
Status
WITHDRAWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2023-09-01
Primary completion
2023-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.